Records containing: Hypertension
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 When Co-administered With Amlodipine 5 mg in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 When Co-administered With Chlorthalidone in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Placebo-Controlled, 5-Arm Titration Study to Evaluate the Efficacy and Safety of TAK-491 When Compared With Valsartan and Olmesartan in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Phase 2, Double-Blind, Randomized, Placebo-Controlled Dose-Ranging Study of the Efficacy, Safety and Tolerability of TAK-491 in Subjects With Mild to Moderate Uncomplicated Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 in Black Subjects With Essential Hypertension
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2011-04-19A One-Year Phase 3, Open-Label Study to Evaluate the Safety and Tolerability of TAK-491 in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Valsartan in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19A Double-Blind, Randomized, Parallel-Group Study to Compare the Efficacy and Safety of TAK-491 With Ramipril in Subjects With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-19Sympathetic Nervous System Modulation in Hypertension by Beta-adrenergic Blockade
-
CLINICAL_TRIALS study record update · 2011-04-15The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Severe Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-15Irbesartan in the Treatment of Hypertensive Patients With Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2011-04-15The Efficacy and Safety of Irbesartan/HCTZ Combination Therapy as First Line Treatment for Patients With Moderate Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-14A Descriptive Pharmaco-epidemiological Study of a Hypertensive Patient Population Treated With a Fixed-dose Combination of Telmisartan 80 mg and Hydrochlorothiazide 25 mg and of Conditions for the Management of Arterial Hypertension
-
CLINICAL_TRIALS study record update · 2011-04-04Irbesartan In Hypertensive Diabetic Patients
-
CLINICAL_TRIALS study record update · 2011-04-01Irbesartan in Mild to Moderate Hypertensive Patients
-
CLINICAL_TRIALS study record update · 2011-03-31ClinicalTrials.gov study NCT00448162
-
CLINICAL_TRIALS study record update · 2011-03-30Implementation of an Integrated Primary Care Network for Prevention and Management of Cardiometabolic Risks (RCM)
-
CLINICAL_TRIALS study record update · 2011-03-28Hypertension in Hemodialysis
-
CLINICAL_TRIALS study record update · 2011-03-25A 36 Week Randomized, Double-blind, Parallel Group, Multi-center, Active-controlled, Optional Titration Study Comparing an Aliskiren-based Regimen to a Ramipril-based Regimen in Patients ≥ 65 Years Old With Systolic Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-03-25A Randomized, Open-label, Blinded Endpoint, Multi-center, Cross-over Study to Evaluate the Effect of High and Low Sodium Diets on Reduction in Mean 24-hour Ambulatory Blood Pressure in Systolic Hypertensive Patients Treated With Aliskiren (300 mg)
-
CLINICAL_TRIALS study record update · 2011-03-25An Eight Week, Double-blind, Randomized, Multicenter, Parallel Group, Active-controlled Study Comparing the Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg to Ramipril 5 mg in Patients With Essential Hypertension
-
CLINICAL_TRIALS study record update · 2011-03-23A Randomized, Eight Week Double-blind, Parallel-group, Multicenter Study to Evaluate the Efficacy and Safety of the Combination of Aliskiren / Amlodipine (150/10 mg and 300/10 mg) in Comparison With Amlodipine 10 mg in Patients With Essential Hypertension Not Adequately Responsive to Amlodipine 10 mg Monotherapy
-
CLINICAL_TRIALS study record update · 2011-03-17Insulin-induced Microvascular Activity in Patients With Essential Hypertension: a Possible Role for Angiotensin II AT1-receptor Blockers.
-
CLINICAL_TRIALS study record update · 2011-03-17Using an Electronic Personal Health Record to Empower Patients With Hypertension
-
CLINICAL_TRIALS study record update · 2011-03-10A Multi-center, Prospective, Randomized, Open-label Study With Blinded Outcome Evaluation to Evaluate the Effects of Systolic Blood Pressure Lowering to Different Targets (Less Than 130 mmHg vs. Less Than 140 mmHg) on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction